| pubmed-article:18464016 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18464016 | lifeskim:mentions | umls-concept:C0029456 | lld:lifeskim |
| pubmed-article:18464016 | lifeskim:mentions | umls-concept:C0026336 | lld:lifeskim |
| pubmed-article:18464016 | lifeskim:mentions | umls-concept:C0442027 | lld:lifeskim |
| pubmed-article:18464016 | lifeskim:mentions | umls-concept:C0014899 | lld:lifeskim |
| pubmed-article:18464016 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:18464016 | lifeskim:mentions | umls-concept:C0005508 | lld:lifeskim |
| pubmed-article:18464016 | pubmed:dateCreated | 2008-5-8 | lld:pubmed |
| pubmed-article:18464016 | pubmed:abstractText | To measure the oral bioavailability of estetrol (E(4)) in rats relative to its subcutaneous administration and to test the bone-sparing effect of oral E(4) compared to that of ethinylestradiol (EE). | lld:pubmed |
| pubmed-article:18464016 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18464016 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18464016 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18464016 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18464016 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18464016 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18464016 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18464016 | pubmed:issn | 1473-0804 | lld:pubmed |
| pubmed-article:18464016 | pubmed:author | pubmed-author:ChristiansenC... | lld:pubmed |
| pubmed-article:18464016 | pubmed:author | pubmed-author:VisserMM | lld:pubmed |
| pubmed-article:18464016 | pubmed:author | pubmed-author:HolinkaC FCF | lld:pubmed |
| pubmed-article:18464016 | pubmed:author | pubmed-author:Coelingh... | lld:pubmed |
| pubmed-article:18464016 | pubmed:author | pubmed-author:HeegaardA-MAM | lld:pubmed |
| pubmed-article:18464016 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18464016 | pubmed:volume | 11 Suppl 1 | lld:pubmed |
| pubmed-article:18464016 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18464016 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18464016 | pubmed:pagination | 2-14 | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:meshHeading | pubmed-meshheading:18464016... | lld:pubmed |
| pubmed-article:18464016 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18464016 | pubmed:articleTitle | Oral bioavailability and bone-sparing effects of estetrol in an osteoporosis model. | lld:pubmed |
| pubmed-article:18464016 | pubmed:affiliation | Pantarhei Bioscience, Zeist, The Netherlands. | lld:pubmed |
| pubmed-article:18464016 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18464016 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
